A detailed history of Nemes Rush Group LLC transactions in Organon & Co. stock. As of the latest transaction made, Nemes Rush Group LLC holds 425 shares of OGN stock, worth $7,191. This represents 0.0% of its overall portfolio holdings.

Number of Shares
425
Previous 425 -0.0%
Holding current value
$7,191
Previous $7.99 Million 10.1%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$10.95 - $17.32 $43 - $69
-4 Reduced 0.93%
425 $6.13 Million
Q3 2023

Nov 09, 2023

SELL
$16.59 - $23.77 $4,960 - $7,107
-299 Reduced 41.07%
429 $7.45 Million
Q2 2023

Aug 02, 2023

BUY
$19.27 - $24.63 $14,028 - $17,930
728 New
728 $15.2 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.3B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.